Technical Analysis for CARA - Cara Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 18.09 | 0.06% | 0.01 |
CARA closed up 0.06 percent on Friday, March 5, 2021, on 1.23 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical CARA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.06% | |
| Lower Bollinger Band Touch | Weakness | 0.06% | |
| Oversold Stochastic | Weakness | 0.06% | |
| Stochastic Buy Signal | Bullish | -4.44% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Lower Bollinger Band Support | 2 days ago | |
| Down 1 ATR | 2 days ago | |
| 1.5x Volume Pace | 2 days ago | |
| Down 5% | 2 days ago | |
| Down 3% | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/25/2021
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Piperidines Mesoblast Acute And Chronic Pain
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Clinical Trial Chronic Pain Amines Piperidines Mesoblast Acute And Chronic Pain
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.6 |
| 52 Week Low | 8.88 |
| Average Volume | 518,255 |
| 200-Day Moving Average | 16.21 |
| 50-Day Moving Average | 18.32 |
| 20-Day Moving Average | 19.62 |
| 10-Day Moving Average | 19.02 |
| Average True Range | 1.08 |
| ADX | 22.11 |
| +DI | 17.16 |
| -DI | 31.40 |
| Chandelier Exit (Long, 3 ATRs ) | 19.35 |
| Chandelier Exit (Short, 3 ATRs ) | 20.02 |
| Upper Bollinger Band | 21.50 |
| Lower Bollinger Band | 17.75 |
| Percent B (%b) | 0.09 |
| BandWidth | 19.12 |
| MACD Line | -0.05 |
| MACD Signal Line | 0.27 |
| MACD Histogram | -0.3222 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 20.15 | ||||
| Resistance 3 (R3) | 19.93 | 19.04 | 19.80 | ||
| Resistance 2 (R2) | 19.04 | 18.51 | 19.14 | 19.69 | |
| Resistance 1 (R1) | 18.56 | 18.19 | 18.80 | 18.78 | 19.57 |
| Pivot Point | 17.67 | 17.67 | 17.79 | 17.77 | 17.67 |
| Support 1 (S1) | 17.19 | 17.14 | 17.43 | 17.41 | 16.61 |
| Support 2 (S2) | 16.30 | 16.82 | 16.40 | 16.49 | |
| Support 3 (S3) | 15.82 | 16.30 | 16.38 | ||
| Support 4 (S4) | 16.04 |
